Clinical Trial: A Randomized Controlled Trial of AI-LIT Intervention for Cyberchondria Under Generative AI Scenarios: The CMIS Framework and Dual-System Theory Perspective (China)

China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized Controlled Trial of AI-LIT Intervention for Cyberchondria Under Generative AI Scenarios: The CMIS Framework and Dual-System Theory Perspective'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135886

Registration Time: 2026/11/03

Type: Interventional study

Primary Sponsor: Jishou University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348126

Published by HT Digital Content Services with permission from Health Daily Digest....